Current approaches in small-diameter
vascular grafts for coronary
artery bypass surgeries fail to address physiological variations along
the graft that contribute to thrombus formation and ultimately graft
failure. We present an innovative interlayer drug delivery system
that can be utilized for the sustained delivery of heparin through
a graft with a high degree of temporal and spatial control. A heparin-loaded
gelatin methacrylate (gelMA) interlayer sits within a biohybrid composed
of decellularized bovine pericardium (dECM) and poly(propylene fumarate)
(PPF), and its UV crosslinking is controlled via three-dimensional
(3D) printed shadow masks. The masks can be readily designed to modulate
the incident light intensity on the graft, enabling us to control
the resultant gelMA crosslinking and properties. A high heparin loading
efficiency was obtained in gelMA and was independent of crosslinking.
We achieved sustained heparin release over the course of 2 weeks within
the biohybrid material using the 3D printed mask patterns. High doses
of heparin were observed to have detrimental effects on endothelial
cell function. However, when exposed to heparin in a slower, more
sustained manner consistent with the masks, endothelial cells behave
similarly to untreated cells. Further, slower release profiles cause
significantly more release of tissue factor pathway inhibitor, an
anticoagulant, than a faster release profile. The heparin-loaded gelMA
interlayer we have developed is a useful tool for the temporal and
spatial control of heparin release that supports endothelial function
and promotes an antithrombotic environment.